Taro Pharmaceutical
TARO
#4579
Rank
$1.14 B
Marketcap
$30.58
Share price
-0.62%
Change (1 day)
-36.38%
Change (1 year)

Operating Margin for Taro Pharmaceutical (TARO)

Operating Margin as of February 2023 (TTM): 13.86%

According to Taro Pharmaceutical's latest financial reports and stock price the company's current Operating Margin is 13.86%. At the end of 2022 the company had an Operating Margin of 13.87%.

Operating Margin history for Taro Pharmaceutical from 2001 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
202213.87%-119.47%
2021-71.24%-254.12%
202046.22%-13.23%
201953.27%20.6%
201844.17%-30.74%
201763.77%-4.79%
201666.98%-0.63%
201567.41%15.3%
201458.46%16.79%
201350.06%12.83%
201244.36%7.72%
201141.19%114.47%
201019.20%45.84%
200913.17%-1.67%
200813.39%5.53%
200712.69%-139.13%
2006-32.43%-1423.74%
20052.45%-200.4%
2004-2.44%-110.55%
200323.13%-7.61%
200225.03%23.73%
200120.23%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
24.28%-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
45.11%-99.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
29.90%-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
28.49%-99.68%๐Ÿ‡บ๐Ÿ‡ธ USA
15.36%-99.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.14%-99.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.